Unifying Interpretability and Explainability for Alzheimer's Disease Progression Prediction
원문 초록
Reinforcement learning (RL) has recently shown promise in predicting Alzheimer's disease (AD) progression due to its unique ability to model domain knowledge. However, it is not clear which RL algorithms are well-suited for this task. Furthermore, these methods are not inherently explainable, limiting their applicability in real-world clinical scenarios. Our work addresses these two important questions. Using a causal, interpretable model of AD, we first compare the performance of four contemporary RL algorithms in predicting brain cognition over 10 years using only baseline (year 0) data. We then apply SHAP (SHapley Additive exPlanations) to explain the decisions made by each algorithm in the model. Our approach combines interpretability with explainability to provide insights into the key factors influencing AD progression, offering both global and individual, patient-level analysis. Our findings show that only one of the RL methods is able to satisfactorily model disease progression, but the post-hoc explanations indicate that all methods fail to properly capture the importance of amyloid accumulation, one of the pathological hallmarks of Alzheimer's disease. Our work aims to merge predictive accuracy with transparency, assisting clinicians and researchers in enhancing disease progression modeling for informed healthcare decisions. Code is available at https://github.com/rfali/xrlad.
함께 살펴볼 논문
공통 태그를 근거로 연결했습니다. 실제 인용 관계나 논문의 우수성을 뜻하지 않습니다.
Fully Offline Reinforcement Learning
High-Throughput Distributed Reinforcement Learning via Adaptive Policy Synchronization
Personalized Exercise Recommendation with Semantically-Grounded Knowledge Tracing
Bridging the Gap in Vision Language Models in Identifying Unsafe Concepts Across Modalities
Exploring the robustness of TractOracle methods in RL-based tractography
Reasoning or Memorization? Unreliable Results of Reinforcement Learning Due to Data Contamination
토론
이 논문과 연결된 포럼 글이 아직 없습니다.